HomePressPress Releases
Results 1 to 10 of total 382
2020-02-04
HZI-developed app for disease control is expanded to stop the spread of the pathogen
2020-01-03
HZI researchers show that nanotechnology improves pharmacological properties of the drug
2019-12-16
Researchers at the HZI and the TU Munich repurpose drug as MRSA treatment
2019-12-12
Researchers from HIRI and the Max Planck Society develop a thermodynamic model to study frameshifting
2019-12-10
ERC Consolidator Grant for HIRI researcher Chase Beisel
2019-12-09
Bill & Melinda Gates Foundation funds collaboration of the HZI/HIPS with Evotec to develop new drug approaches for treating tuberculosis and malaria
2019-11-29
Das Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS), die Universität des Saarlandes und das Leibniz-Institut für Neue Materialien vereinbaren eine interdisziplinäre Kooperation in der biomedizinisch-pharmazeutischen Wirkstoffforschung
2019-11-27
HZI spin-off Myxobiotics researches active substance against urinary tract infections
2019-11-22
Researchers at HIRI and Duke University are using a previously unexplored class of the CRISPR-Cas system
2019-11-21
Dirk Bockmühl, Professor für Hygiene und Mikrobiologie, liest am 28. November 2019 im Haus der Wissenschaft aus seinem aktuellen Sachbuch.
